Payer Decision-Making for Next Generation Sequencing-Based Genetic Tests: Insights from cell-free DNA prenatal genetic screening

Documenti analoghi

• Decision-Making on Medical Innovations in a Changing Healthcare Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies
  di: Trosman, Julia R., et al.
  Pubblicazione: (2017)
• Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing–Based Tests: Challenges, Opportunities, and Potential Solutions
  di: Deverka, Patricia A., et al.
  Pubblicazione: (2020)
• Payer coverage policies for multigene tests
  di: Phillips, Kathryn A, et al.
  Pubblicazione: (2017)
• Challenges of Coverage Policy Development for Next-Generation Tumor Sequencing Panels: Experts and Payers Weigh In
  di: Trosman, Julia R., et al.
  Pubblicazione: (2015)
• Perspectives of U.S. Private Payers on Insurance Coverage for Pediatric and Prenatal Exome Sequencing – Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)
  di: Trosman, Julia R., et al.
  Pubblicazione: (2019)